Commercial Partners 2018

If you are interested in sponsoring the Global Drug Delivery and Formulation Summit please contact:

Tel:+ 44 (0)20 3874 9205

Adare Pharmaceuticals

Adare is a global specialty pharmaceutical company inspired to create new possibilities for patients whose treatment needs are not fully addressed by current medications.

With a growing pipeline, focused R&D efforts, and global manufacturing capabilities, Adare is actively exploring value creation through development and expansion across therapeutic areas. Adare has a proven track record from concept through commercialization that can help you overcome formulation challenges and add valuable IP to your current and future products.

Formulation challenges? Experience a partnership focused on the needs of patients and your company’s goals, contact us at


ADM-SIO is a global leading manufacturer of pharmaceutical grade oils (soybean, olive, sesame) used as API’s or excipients for oil-soluble drugs. As a subsidiary of Archer Daniels Midland Company (ADM) –– ADM-SIO offers an extensive range of highly purified oils, derived from vegetable origins that meet all relevant pharmaceutical regulations and manufactured according to cGMP standards. Our highly purified pharmaceutical oils are used as API’s (CEP for soybean and olive oils) in large volume emulsions for parenteral nutrition and as excipients (US DMF type IV for soybean, olive and sesame oils) in injectable, oral or topical formulations.


Agilent Technologies Inc. is a technology leader in life sciences and diagnostics. Agilent has a strong focus on the Pharmaceutical space and provides analytical solutions to researchers ranging from sample prep to analysis. The company has about 13500 employees globally and had revenues of $4.47 billion in fiscal year 2017.

Aplicaps by Clover (CDMO)

Aplicaps by Clover (CDMO) is one of the main Southern Europe softgels manufacturers for consumers health and pharmaceuticals products. Companies from +30 countries have trusted us to develop and manufacture their unique softgels. Our pillars: customer service, quality and innovation. Tailored/stock formulas. Bulk/finished products.

Armor Pharma

ARMOR PHARMA manufactures and markets 3 ranges of pharmaceutical grade lactose for all your applications:

  • ARMOR PHARMA™ lactose monohydrate : sieved & milled lactose
  • EXCIPRESS™ lactose for Direct Compression
  • EXCIPURE™ lactose for Dry powder Inhalation

Our state of the art industrial facility, located in Brittany, FRANCE, is in full compliance with pharmaceutical standards ( EXCiPACT, cGMP, GDP, PAT) and enables the production of lactose in line with pharmaceutical regulations: Ph-EU, USP-NF, and JP.

ARMOR PHARMA's ambition is to design solutions that best support customer's development. Our positionning reflects this philosophy, centred on a question that makes sense: "How would you like your lactose?"

For more information, or to tell us how you would like your lactose:


Albumedix® is the market leader in recombinant human albumin and drug-enhancing, albumin-based technologies. As the highest quality recombinant hu¬man albumin ever developed, Albumedix enables the effective formulation of otherwise hard-to-stabilize drugs, cell therapies, and vaccines. Building upon its unique albumin-based, drug-enhancing technologies and a strong, partnered drug pipeline, Albumedix de¬velops proprietary drug candidates that address unmet patient needs. With more than 30 years of experience, and after successfully developing several albumin-enabled drugs in partnership, today Albumedix is dedicated to improving the health of people with serious and chronic diseases.

Cambridge Design Partnership

Cambridge Design Partnership is a leading product and technology innovation partner with offices in Cambridge, UK and Palo Alto, USA. We are experienced in drug delivery device design, development, prototype and short-run manufacturing for some of the world’s largest companies. Our experts in engineering, human factors and industrial design are able to take combination products through a full design cycle and submission, to enable you to launch a product that is customer focused and commercially effective. Certified to ISO 13485/9001.

For more information, visit


confinis is a global consulting firm specializing in combination products. We are based in Switzerland and the USA. Our range of services includes

  • Regulatory affairs
  • Quality System Management / Optimization
  • Usability engineering / human factors studies
  • Post market surveillance
  • Design control
  • Risk management
  • Clinical evaluations
  • Auditing and training

Additionally, we offer our innovative approach to the modular construction of Design History Files (DHF), enabling a quantum leap in the maintenance of DHFs. Depending on the customers’ needs, we provide support throughout the product development process and post market surveillance operations; or we support certain aspects like regulatory strategy development or the design control process. Our consultants hands-on experience enables confinis the ability to offer unique and wide-ranging services related to designing and manufacturing medical devices and combination products.

Visit our website and follow us on LinkedIn.

Datwyler Pharma Packaging International

Datwyler Sealing Solutions is a leading industrial supplier and a key player in the global health care world. Our state-of-the-art solutions for drug packaging and medical devices, build on over 100 years of experience. Within our health care offering and its three pillars Bio Care, Pharma Care and Med Care, we provide a unique range of products and services including the most advanced elastomer formulations, coatings, aluminum seals, and processing technologies. Partnering up with the world’s top pharmaceutical and medical companies, we are a vital link and stand by our mission to ensure all patient’s safety and improve patients’ lives.

For more information, visit

DFE Pharma

DFE Pharma is the global leader in excipient solutions. We develop, produce and market excipients for oral solid dose and dry powder formulations with a heritage in lactose, starch and superdisintegrants. With the addition of MCC to our portfolio DFE Pharma uniquely offers world's main excipient categories, unlocking potential synergies for you to increase your efficiency. Contact us on

Dow Pharma & Medical

Dow Pharma & Medical is a global leader in research, manufacturing and innovation of functional excipients, API’s and silicon-based technologies for medical device fabrication and pharmaceutical processing. It has the material science expertise and global market and regulatory experience to help customers deliver innovative solutions for healthcare challenges of today and tomorrow; bringing new products to market faster and extending product life-cycles. Whether you are creating modified release medicines, seeking to enhance the solubility of Active Pharmaceutical Ingredients for therapeutic effect, or simply looking for efficient wound care through soft skin adhesives, we can take you there.

Dow will highlight specific solutions on solubility enhancement:

– New possibilities using AFFINISOL™ excipients – exploring a platform of tailored polymers for solubility enhancement

Well-known brands for:

  • Solubility Enhancement
  • Modified Release
  • Taste Masking
  • Tablet or Enteric Coating
  • Binders
  • Stabilizers
  • Rheology Modifiers
  • Adhesives
  • Antifoams and Antifoam Simethicone Emulsions
  • Fluids, Emulsions and Dispersions
  • Topical Excipients
  • Topical Ingredients
  • Rubber and Elastomers
  • Tubing and Molded Assemblies

Enable Injections

Enable Injections is a late-stage startup company that has developed the enFuseTM wearable platform, a disposable wearable infuser that delivers high volume (up to 50 ml), high viscosity drug/biological products to the subcutaneous tissue. The system utilizes standard container closures (syringes or vials) to fill the infuser and can automatically mix solutions or solubilize lyophilized product if required. It is designed to be simple to use and discreet promoting convenience and comfort for a preferred injection experience for the user. Enable’s technology provides many differentiating advantages to both the user and bio-pharmaceutical company. Founded by medical device veterans the company has R&D, Operations and Manufacturing facilities in Cincinnati, Ohio.

Foster Delivery Science

Foster Delivery Science focuses solely on Hot Melt Extrusion and extrusion processes to blend client API’s with polymers for several possible purposes: Solubility and bioavailability enhancement; create local delivery solutions such as drug loaded films, implants and fibers; create delivery or release profiles; and capture the powerful mixing capabilities of twin screw extruders. Operating from our new GMP facility 75 minutes from Boston in CT, we provide formulation development services, scale up, clinical trial material and ready for GMP manufacturing.


Glatt Pharmaceutical Services is a CDMO for solid pharmaceutical dosage forms. Our focus is on multiparticulate systems such as pellets, micropellets and granules. Whether you are looking for optimal bioavailablity or taste masking, improved solubility or stabilization of the dosage form, we have the right solution for every challenge. Glatt Pharmaceutical Services brings together fundamentals, experience and innovative technology expertise. With our comprehensive services, we support you from product idea to market launch.


Grace, built on talent, technology and trust, is a premier specialty chemicals company that provides innovative products, technologies and services that support pharmaceutical development and manufacturing. As a worldwide leader in specialty silica gel manufacturing, Grace’s portfolio of solutions for the pharmaceutical industry include SYLOID® formulation excipients, SILSOL® silica-based drug delivery technologies, custom intermediates and regulatory starting materials, and VYDAC® and DAVISIL® bulk chromatographic resins.

Harke Pharma

Harke Pharma is a technological driven distributor based in Mülheim, Germany. We offer a wide range of high quality excipients suitable for the development of solid and semi-solid dosage forms. Our technicians offer formulation assistance for classical techniques like instant release or enteric coating, direct compression or granulation, controlled release matix development or layering and extrusion spheronisation processes. Additionally, we offer solutions for the development of solid dispersions, in case of hot melt extrusion, development of mini tablets, etc. Benefit from our experience to set up innovative formulations based on high class excipients.


Hovione offers customized services and innovative solutions from drug substance to drug product, with all activities performed at the same site, providing a fully integrated service for clinical and small commercial scale complex drug product development and manufacturing. As the Leader in Commercial Spray Drying, Hovione can handle projects from development to market. Our particle engineering technologies can address challenges in solubility enhancement, lung delivery, modified release and taste-masking applications and can handle highly potent compounds. Hovione also offers integrated inhalation development services. We do well what is difficult, to give our customers what they cannot find elsewhere.


Profile coming soon

IWA Consulting

IWA Consulting Team has specialized in assisting our clients from development to launch and life cycle management of pharmaceuticals and medical devices. We provide regulatory and medical affairs services to a large range of international private and public clients based on long term regulatory experience and in-depth knowledge. IWA Consulting Team offers full eCTD support for all regions where we have a long term hands on experience in eCTD compiling with focus on global eCTD submissions, where possible. We trust that doing things right from start is the fastest and most efficient route to reach the goal.


Leon-nanodrugs GmbH (Munich) is a nanotechnology-based drug development company focused on development of novel oral and parenteral formulations and innovative drug combinations.

The proprietary and patent-protected MicroJetReactor Technology by leon-nanodrugs is a bottom-up approach for nano- and microparticle synthesis. Basis of the process is a continuous solvent / non-solvent precipitation that is performed under precisely controlled process conditions.

Build on its “network of expertise”, leon-nanodrugs can provide a 360 degree competence range – from concept to product approval.

Leon-nanodrugs proprietary MJR® Technology offers access to the next generation nano formulated drugs with added patient benefits and economical values for its partners and shareholders.

Lonza Pharma & Biotech

Lonza Pharma & Biotech provides global contract development and manufacturing services that enable pharma and biotech companies to bring medical innovations to patients in need. We are recognized for our reliability and high-quality, our global capacity, our innovative technology platforms, and our extensive experience. We have helped to commercialize pioneering therapies and we continuously invest and innovate to meet your expectations also for future medicines. Our belief is that the best outcome –for you and for your patients –comes as a result of a successful collaboration. Together, we can solve the next challenge and bring your next medicine to life.

For more information, visit

Losan Pharma

70% of the NCE´s have a certain problem (solubility, stability, bioavailability, variability) which limits their potential use. Losan is a privately owned company and has beside the conventional technologies a broad platform for innovative technologies like (i) Solubilisation technologies such as Nanoparticulate , HME-based or Amorphous Silica formulations with proven in-vivo results, (ii) Pellet/Coating technology for target release formulations (iii) Stick pack technology for high dose and convenience application (iv) OTC innovations. Our strategy is to help companies with the design and solutions of their specific API formulations needs. A strong analytical support (DoE, QbD, ivivc correlation,) completes our approach.

LTS Lohmann

LTS is the global leader in the development and manufacture of transdermal systems and oral thin films with additional innovative technologies in development. The products developed by LTS comprise a multitude of innovations, such as first and only patch for treatment of Alzheimer and the only patch against Parkinson’s and Restless-Legs-Syndrome, which is the first medication in the world available only as a patch.

The innovation capability of LTS led the way for oral thin film products on the market with the introduction of Listerine® Pocketpaks®, which dominate the North American market. LTS supports its cooperation partners from product inception through commercialization in our FDA approved facilities in Germany and USA.

More than 3,000 patents reinforce the top position of LTS group in development of its technologies.

LTS Lohmann services include:

  • Feasibility studies
  • Full product development
  • Clinical studies phase I-IV
  • Scale-up and process development
  • Commercial manufacturing

For transdermal therapeutic systems, topical patches and oral thin films (OTF)

Medical Device Usability

Medical Device Usability, a human factors and usability consultancy based in Cambridge, UK, is pleased to be sponsoring DDF 2018. With a well-established track record of carrying out usability testing on a wide range of pharmaceutical and medical devices and combination products, MDU HF specialists can discuss and advise on any usability requirements whether for a new product idea or one that is close to completion.

Medical Device Usability regularly carries out formative and validation studies in the US, UK and Europe and offers a complete start to finish usability service including writing and preparing all the necessary documentation including study protocol, report and HF Engineering file as well as conducting the testing.

The MDU team work with a broad range of clients from global pharma through to small start-ups.

If you have a specific medical device or pharmaceutical product or just want to find out how we may be able to help with any HF and usability requirements please get in touch at the conference or at

Meggle Excipients & Technology

MEGGLE Excipients & Technology is a global leader in manufacturing lactose for the pharmaceutical industry. We offer a broad product portfolio of lactose excipients, co-processed technologies and excipient contract manufacturing.

MEGGLE is a pioneer in co-processing technologies and developed highly functional excipients possessing unique qualities for directly compressible immediate and sustained release pharmaceutical solid dosage forms.


  • Lactose monohydrate
  • Anhydrous Lactose
  • Co-Processed Excipients
  • Lactose for Inhalation
  • Lactose for lyophilization and parentral applications
  • Tailor-made lactose products


  • Spray drying
  • Co-Processing
  • Agglomeration
  • Product Customization

Merck KGaA

Merck KGaA, Darmstadt, Germany is a leading science and technology company in healthcare, life science and performance materials. We offer more than 400 pharmaceutical formulation raw materials for solid, liquid and semi-solid dosage forms, a wide range of active pharmaceutical ingredients and drug delivery compounds which include activated PEGs, lipids, PEG lipids for bioavailability enhancement. In addition, our Emprove® Program provides extensive regulatory documentation to facilitate risk assessment and qualification processes. Through dedicated collaboration on new scientific and engineering insights, we serve as a strategic partner to help advance the promise of life saving therapies. For more information on the company's portfolio, please click here.


MUNIT is a new and innovative consultancy company, operating in the field of MICRONIZATION of Active Pharmaceutical Ingredients (APIs), High Potent APIs, Cytotoxic and Cytostatic compounds, Inhalation products, Steroids, R&D compounds and Generics.

In MUNIT we have combined the technical and commercial expertise of its affiliates Jetpharma SA (Switzerland) and Microchem Srl (Italy) making the best out of 40 years of leadership.

MUNIT is your direct access point to Jetpharma’s and Microchem’s services, such as:

  • Jet- , Pin- and Hammer milling
  • Co- and cryogenic micronization
  • Sieving, Blending, De-Lumping
  • Technical trials, DOE Studies, Process development and validation
  • PSD analysis etc.


Profile coming soon


Patheon, a part of Thermo Fisher Scientific, provides end-to-end pharmaceutical services to support the entire biotechnology and pharmaceutical lifecycle. Thermo Fisher’s pharma services solutions helps customers accelerate innovation and drive productivity in the drug development and commercialization process – from small and emerging to large biotechnology and pharmaceutical companies for both large and small molecules.


Pfanstiehl Inc. is a cGMP Manufacturer of High Purity Low Endotoxin components such as Trehalose, Sucrose, Mannitol, Maltose, Galactose (non-animal), Mannose and Ribose for Biologics, Biosimilars, Vaccines, Cell Culture Media and Injectables (liquid & lyo) located in Waukegan Illinois USA. Pfanstiehl has been in operation since 1919, focusing on both Biopharmaceutical excipients / critical components & Pharmaceutical HPAPIs / APIs (generic and on contract manufacturing base). Pfanstiehl specializes in isolation, purification, custom synthesis and scale-up development of regulated, high purity and low endotoxin Injectable Formulation Ingredients, Pharmaceutical Intermediates and Active Pharmaceutical Ingredients, in gram to multi-ton commercial quantities.

PMC Isochem

Acquired by PMC International in December of 2017, PMC Isochem is a world leader in custom pharmaceutical manufacturing. PMC Isochem offers integrated business comprised of research, product/process development, regulatory approvals, pilot scale and full plant-scale production of drug intermediates and active pharma ingredients (APIs) for major pharmaceutical companies worldwide. PMC Isochem facilities located near Paris combine a footprint of over 40 acres with three cGMP US-FDA audited sites Gennevilliers, Pithiviers, and Vert-Le-Petit. We are masters of complex processes and can manufacture products to the most stringent pharmaceutical regulatory standards.

PMC Isochem primarily serves the pharmaceutical market and several other markets with:

  • Custom and Generic APIs
  • Chemical intermediates (cGMP or non cGMP)
  • Phosgene derivatives including activated amino acids NCA – UNCA
  • Vitamin E TPGS and derivatives
  • Anti-scratch varnishes

32 rue Lavoisier
Phone +33 (0)1 64 99 03 00
Fax +33 (0)1 64 99 03 50


PolyPid Ltd. is a clinical stage biopharmaceutical company developing products based on its proprietary PLEX™ local drug delivery platform. PLEX™ is revolutionizing medicine by enabling the development of localized, controlled and prolonged therapeutics. PLEX™ is setting new standards by enabling effective release directly at the target site for a prolonged duration up to several months predetermined according to medical needs. PLEX™ fits any size or physical characteristics of drugs. Our PLEX™ based anti-infective products have demonstrated an excellent performance in clinical studies introducing best in class drugs for surgical site infection management. Partnering with PolyPid could allow the creation of a new category of differentiated medicines in multiple therapeutic areas.

Precision NanoSystems Inc (PNI)

Precision NanoSystems Inc (PNI) creates innovative solutions for the discovery, development and manufacture of novel nanoparticles for use as medicines and in medical research. PNI’s proprietary NanoAssemblr Platform enables the rapid, reproducible, and scalable manufacture of next generation nanoparticle formulations for the targeted delivery of therapeutic and diagnostic agents to cells and tissues in the body. PNI provides instruments, reagents and services to life sciences researchers, including pharmaceutical companies, and builds strategic collaborations to revolutionize healthcare through nanotechnology.

ProMed Pharma

ProMed Pharma specializes in the molding of drug-loaded silicones and thermoplastics and leverages this expertise to manufacture long-term implants and combination devices under cGMP. Working with established and early stage companies, we utilize robust manufacturing processes for controlled release of APIs utilizing a variety of materials. From clinical trial materials to commercial products, ProMed supports pharmaceutical and medical device companies developing controlled release formulations including subcutaneous, orthopedic, cardiovacular, and ophthalmic implants, intravaginal rings, and steroid-eluting components.

Please visit

Quotient Sciences

Quotient Sciences is dedicated to accelerating the development of new drugs for patients around the world. We provide formulation development, clinical pharmacology trials, and clinical and commercial manufacturing services to the pharmaceutical and biotech industry. These services are provided either individually or as an integrated service offering via our Translational Pharmaceutics® platform.



Renishaw is one of the world's leading engineering and scientific technology companies, with expertise in precision measurement and healthcare. The company supplies products and services used in applications as diverse as jet engine and wind turbine manufacture, through to 3D printing, dentistry and brain surgery.

The Renishaw Group currently has more than 70 offices in 35 countries, with over 4,000 employees, of which 2,800 people are employed within the UK. For the year ended June 2017 Renishaw achieved sales of £536.8 million of which 95% was due to exports. The company's largest markets are China, USA, Germany and Japan.

Revox Sterilization Solutions

The REVOX® sterilization process uses a room-temperature vaporized peracetic acid (VPA) method that achieves exceptionally low chemical residuals and unsurpassed materials compatibility. The REVOX technology eliminates inefficiencies associated with pre-conditioning and lengthy post sterilization wait times. This allows REVOX to offer manufacturers a quick-turn, off-site sterilization service or cost efficient on-site, in-line processing. With the 3000L machine, or 417L, REVOX enables in-line sterilization, allowing companies to safely and easily integrate sterilization into a lean manufacturing process with no exhaust or other special infrastructure needed. In 2014 a Class II implantable device was granted FDA clearance with the REVOX sterilization process.


ROQUETTE “Improving well-being by offering the best of nature”

A family-owned Group serving customers globally, Roquette is a leader in specialty food ingredients and pharmaceutical excipients. The products and solutions developed by the Group deliver proven technological, nutritional and health benefits precisely tailored to the pharma, nutrition, food and selected industry markets. Roquette’s offer is produced from plant based raw materials such as corn, wheat, potatoes and peas.

Since its foundation over 80 years ago, the Group’s growth has been based on innovation, a passion for the job and a commitment to achieve. Roquette operates in over 100 countries, has a turnover of around 3.3 billion euros and currently employs more than 8,000 people worldwide.

Shin-Etsu Pharma & Food Materials Distribution GmbH

Shin-Etsu PFMD is the distribution organization of Shin-Etsu Chemical Co., Ltd. Japan and SE Tylose, Wiesbaden Germany and is registered in Wiesbaden. It is located at the Industrial Park Kalle-Albert in Wiesbaden. Together with our distributors, we are the exclusive business partners for our customers and multi national key accounts in the pharmaceutical- and the food industry.

SE PFMD manages a regional, centralized warehouse for all products to be able to supply the customers in Europe on short-term base whenever necessary. SE PFMD will manage logistic for customers in other regions independent from Shin-Etsu´s production sites. For our pharma customers we offer with our technical application lab the possibility to optimize their processes if required. Our products are covering a very wide range of applications and they fully comply with FDA, USP/NF, JP and EP requirements.

Pharmaceutical Excipients: Cellulose ether excipient is a pharmacologically inactive substance used as a carrier for the active ingredients in medication.

PHARMACOAT® – Water-Soluble Film Coating Agent
METOLOSE® – Binder and Thickening Agent
METOLOSE® SR – Sustained release agent for hydrophilic matrix system
L-HPC – Disintegrant with Binding Properties, Multifunctional Excipient
HPMCP – Enteric Coating Agent
Shin-Etsu AQOAT® – Enteric Coating Agent, Solid Dispersion Polymer
Tylopur® – Low- and high viscosity Hypromellose


Our core competencies consist of design, development and production of mechatronic drive systems. Since 1936, our focus has been on innovation, best in class quality and service which is our key to success for worldwide OEM customers. Sonceboz is ISO 13485 certified and active in wearable drug delivery, medical devices and laboratory industry.

Pharma companies looking for Large Volume Injectors for high viscosity drugs, Dual Cartridge or Auto-reconstitution Injectors will find interesting solutions in Sonceboz's new drug Delivery Device Platform. Customized technology modules like motor-drives, electronics, pumps and needle insertion systems are available for Medical device manufacturers.

Rue Rosselet Challandes - 5

Unchained Labs

Here’s the deal. We’re all about helping biologics researchers break free from tools that just don’t cut it. Unleashing problem-tackling products that make a huge difference in the real science they do every day. That’s our mantra, our promise and we own it.

W.L. Gore & Associates, Inc

W. L. Gore & Associates is a global materials science company dedicated to transforming industries and improving lives. Founded in 1958, Gore has built a reputation for solving complex technical challenges in the most demanding environments — from revolutionizing the outerwear industry with GORE-TEX® fabric to creating medical devices that improve and save lives to enabling new levels of performance in the aerospace, pharmaceutical and mobile electronics markets, among other industries. As a business initiative within the Enterprise, Gore PharmBIO Products develops high-performance, technology-driven products to better serve the global pharmaceutical, bioprocessing and medical device markets. All products in the Gore PharmBIO Products portfolio are tested and manufactured under stringent quality systems. These high-performance products provide creative solutions to our customers’ design, manufacturing, and performance-in-use needs.

Commercial Partners: